Ironwood Pharmaceuticals Appoints Tammi Gaskins as Chief Executive Officer
Ironwood Pharmaceuticals appointed Chief Commercial Officer Tammi Gaskins as CEO and board member, effective January 1, 2027, succeeding retiring CEO Tom McCourt. McCourt, CEO since 2021 and a 17-year Ironwood veteran, will remain on the Board, providing transition continuity. The Board cited Gaskins' role in returning LINZESS to blockbuster status and her leadership of the apraglutide commercial strategy.
Key figures
- Effective Date
- January 1, 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.